603079 Stock Overview
Zhejiang Shengda Bio-Pharm Co., Ltd. develops, produces, and sells food and feed additives for pharmaceutical, nutritional, food, and animal feed industry.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Zhejiang Shengda Bio-Pharm Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥9.38 |
| 52 Week High | CN¥16.24 |
| 52 Week Low | CN¥7.01 |
| Beta | 0.40 |
| 1 Month Change | -9.11% |
| 3 Month Change | -26.55% |
| 1 Year Change | -24.96% |
| 3 Year Change | -57.03% |
| 5 Year Change | -49.32% |
| Change since IPO | -15.39% |
Recent News & Updates
Shareholder Returns
| 603079 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -10.4% | -0.7% | -0.2% |
| 1Y | -25.0% | -15.9% | -17.8% |
Return vs Industry: 603079 underperformed the CN Pharmaceuticals industry which returned -15.9% over the past year.
Return vs Market: 603079 underperformed the CN Market which returned -17.8% over the past year.
Price Volatility
| 603079 volatility | |
|---|---|
| 603079 Average Weekly Movement | 13.0% |
| Pharmaceuticals Industry Average Movement | 7.9% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 603079's share price has been volatile over the past 3 months.
Volatility Over Time: 603079's weekly volatility has increased from 7% to 13% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 1,152 | Bin Zhou | www.sd-pharm.com |
Zhejiang Shengda Bio-Pharm Co., Ltd. develops, produces, and sells food and feed additives for pharmaceutical, nutritional, food, and animal feed industry. It offers vitamins, such as biotin and folic acid; biological preservatives, including nisin and natamycin; and intermediate APIs. The company is based in Tiantai, China.
Zhejiang Shengda Bio-Pharm Co., Ltd. Fundamentals Summary
| 603079 fundamental statistics | |
|---|---|
| Market cap | CN¥1.61b |
| Earnings (TTM) | -CN¥18.19m |
| Revenue (TTM) | CN¥746.22m |
2.1x
P/S Ratio-88.0x
P/E RatioIs 603079 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603079 income statement (TTM) | |
|---|---|
| Revenue | CN¥746.22m |
| Cost of Revenue | CN¥664.48m |
| Gross Profit | CN¥81.73m |
| Other Expenses | CN¥99.93m |
| Earnings | -CN¥18.19m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 20, 2024
| Earnings per share (EPS) | -0.11 |
| Gross Margin | 10.95% |
| Net Profit Margin | -2.44% |
| Debt/Equity Ratio | 13.5% |
How did 603079 perform over the long term?
See historical performance and comparison